Acquisitions2 Jun 2026, 05:42 pm
Mankind Pharma subsidiary acquires remaining 10% stake in Upakarma
AI Summary
Mankind Pharma Ltd announced that its wholly-owned subsidiary, Mankind Lifesciences Private Limited (MLS), has acquired the remaining 10% stake in Upakarma Ayurveda Private Limited from Kaushcorp Media LLP for ₹75 Lakhs. This acquisition, completed on June 2, 2026, makes Upakarma a wholly-owned subsidiary of MLS and a step-down wholly-owned subsidiary of Mankind Pharma. The move is expected to enhance operational efficiencies through streamlined processes. Upakarma Ayurveda operates in the Ayurvedic, herbal, and nutraceutical products sector.
Key Highlights
- Mankind Pharma's subsidiary acquires full control of Upakarma Ayurveda.
- Acquisition cost is ₹75 Lakhs for the remaining 10% stake.
- Upakarma becomes a step-down wholly-owned subsidiary.
- Expected to improve operational efficiencies.
- Upakarma operates in the Ayurvedic and nutraceuticals market.
Price Impact
More from MANKIND